Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Nanda, Rita

One or more keywords matched the following items that are connected to Nanda, Rita

Item Type	Name
Concept	Actins
Concept	Adenocarcinoma
Concept	Age Factors
Concept	Academic Medical Centers
Concept	Alleles
Concept	Breast
Concept	Antineoplastic Agents
Concept	Carcinoma, Squamous Cell
Concept	Aneuploidy
Concept	Antimetabolites, Antineoplastic
Concept	Antibodies, Monoclonal
Concept	Benzamides
Concept	Cell Count
Concept	Cephalometry
Concept	Bayes Theorem
Concept	Azacitidine
Concept	Carcinoma in Situ
Concept	Biopsy
Concept	California
Concept	Colonic Neoplasms
Concept	Contrast Media
Concept	Demography
Concept	Dexamethasone
Concept	DNA Repair
Concept	Cathepsins
Concept	Cyclophosphamide
Concept	Chromosomes, Human, Pair 17
Concept	Insulin-Like Growth Factor II
Concept	Esophagitis
Concept	Liver Neoplasms
Concept	Insulin-Like Growth Factor I
Concept	Hydroxamic Acids
Concept	Keratins
Concept	Carcinoma, Hepatocellular
Concept	Maytansine
Concept	Pharmacogenetics
Concept	Extracellular Matrix
Concept	Immunohistochemistry
Concept	Receptors, Estrogen
Concept	Nigeria
Concept	Prostatic Neoplasms
Concept	Image Processing, Computer-Assisted
Concept	Receptors, Androgen
Concept	Risk Factors
Concept	Cohort Studies
Concept	Cluster Analysis
Concept	Neprilysin
Concept	Carcinoma, Adenosquamous
Concept	Trans-Activators
Concept	Tumor Cells, Cultured
Concept	Vertical Dimension
Concept	Genes, BRCA2
Concept	DNA Modification Methylases
Concept	Genes, Tumor Suppressor
Concept	Mifepristone
Concept	Paclitaxel
Concept	Gene Expression
Concept	Receptor, IGF Type 1
Concept	Postmenopause
Concept	Meningeal Neoplasms
Concept	Carcinoma, Lobular
Concept	Disease Progression
Concept	Carcinoma, Ductal, Breast
Concept	Fluorodeoxyglucose F18
Concept	Angiogenesis Inhibitors
Concept	CpG Islands
Concept	Antineoplastic Agents, Hormonal
Concept	Insulin-Like Growth Factor Binding Protein 3
Concept	Fatal Outcome
Concept	Androgen Receptor Antagonists
Concept	B7-H1 Antigen
Concept	Methylenetetrahydrofolate Reductase (NADPH2)
Concept	MSX1 Transcription Factor
Concept	Genes, BRCA1
Concept	BRCA2 Protein
Concept	Promoter Regions, Genetic
Concept	Receptors, TNF-Related Apoptosis-Inducing Ligand
Concept	Receptors, Glucocorticoid
Concept	Receptors, Progesterone
Concept	Receptors, Steroid
Concept	Senegal
Concept	Specimen Handling
Concept	Electron Transport Complex I
Concept	Taxoids
Concept	Meningeal Carcinomatosis
Concept	Cathepsin K
Concept	Class I Phosphatidylinositol 3-Kinases
Concept	Antibodies, Monoclonal, Humanized
Concept	CTLA-4 Antigen
Concept	Keratin-5
Concept	PTEN Phosphohydrolase
Concept	DNA Copy Number Variations
Concept	Fanconi Anemia Complementation Group F Protein
Concept	Survival Rate
Concept	Receptor, ErbB-2
Concept	DNA Methylation
Concept	Genes, erbB-2
Concept	Cyclin A
Concept	Receptor, TIE-2
Concept	Transcriptome
Concept	Precision Medicine
Concept	Pandemics
Concept	Vascular Endothelial Growth Factor A
Concept	Programmed Cell Death 1 Receptor
Concept	Cell Line, Tumor
Concept	Genes, Neoplasm
Concept	Keratin-6
Concept	Drug Discovery
Concept	Cyclin A1
Concept	Brain Neoplasms
Concept	Clinical Trials as Topic
Concept	Doxorubicin
Concept	Drug Screening Assays, Antitumor
Concept	Follow-Up Studies
Concept	Genetic Testing
Concept	Longitudinal Studies
Concept	Lymphocytes
Concept	Prospective Studies
Concept	Retrospective Studies
Concept	T-Lymphocytes
Concept	Vimentin
Concept	Genetic Predisposition to Disease
Concept	Genomics
Concept	Estrogen Receptor alpha
Concept	Bone Density Conservation Agents
Concept	Drug Recalls
Academic Article	Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
Academic Article	The molecular portraits of breast tumors are conserved across microarray platforms.
Academic Article	BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.
Academic Article	Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
Academic Article	Advances in breast cancer: pathways to personalized medicine.
Academic Article	Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers.
Academic Article	Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer.
Academic Article	"Targeting" triple-negative breast cancer: the lessons learned from BRCA1-associated breast cancers.
Academic Article	A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Academic Article	Targeting the human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancer: recent advances and future directions.
Academic Article	Phase II trial of temsirolimus in patients with metastatic breast cancer.
Academic Article	Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017.
Academic Article	Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development.
Academic Article	The role of tumor-associated macrophages in breast cancer progression (review).
Academic Article	Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006.
Academic Article	A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer.
Academic Article	Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities.
Academic Article	Gene expression of peripheral blood cells reveals pathways downstream of glucocorticoid receptor antagonism and nab-paclitaxel treatment.
Academic Article	TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.
Academic Article	TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer.
Academic Article	Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019.
Academic Article	The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer.
Academic Article	Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).
Academic Article	Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017.
Academic Article	Early and Severe Radiation Esophagitis Associated With Concurrent Sirolimus.
Academic Article	A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer.
Academic Article	Adaptive Randomization of Neratinib in Early Breast Cancer.
Academic Article	Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
Academic Article	Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.
Academic Article	Concepts and targets in triple-negative breast cancer: recent results and clinical implications.
Academic Article	TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis.
Academic Article	Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients.
Academic Article	Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.
Academic Article	Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
Academic Article	Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083.
Academic Article	Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
Academic Article	LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Academic Article	Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.
Academic Article	Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, November 30th 2016.
Academic Article	Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
Academic Article	Retrospective chart evaluation of hypercalcemia management in oncology patients at the University of Chicago Medical Center.
Academic Article	Immune Checkpoint Blockade for Breast Cancer.
Academic Article	Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.
Academic Article	Immune Checkpoint Inhibitor Therapy in Breast Cancer.
Academic Article	Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study.
Academic Article	Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
Academic Article	First international TNBC conference meeting report.
Academic Article	Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.
Academic Article	Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
Academic Article	Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
Academic Article	Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.
Academic Article	Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer.
Academic Article	TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer.
Academic Article	If we build it they will come: targeting the immune response to breast cancer.
Academic Article	TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer.
Academic Article	MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial.
Academic Article	Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial.
Academic Article	Atezolizumab for the treatment of breast cancer.
Academic Article	TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.
Academic Article	Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
Academic Article	Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
Academic Article	Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.
Academic Article	Racial disparities in survival outcomes among breast cancer patients by molecular subtypes.
Academic Article	TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.
Academic Article	Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial.
Academic Article	Novel therapies for triple-negative breast cancer.
Academic Article	First-in-human evaluation of the novel mitochondrial complex I inhibitor ASP4132 for treatment of cancer.
Academic Article	Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer ("METRIC"): a randomized multicenter study.
Academic Article	Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.
Academic Article	Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
Academic Article	Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial.
Academic Article	Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors.
Academic Article	The impact of site-specific digital histology signatures on deep learning model accuracy and bias.
Academic Article	Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update.
Academic Article	Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer.
Academic Article	Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.
Academic Article	The emerging role of immune checkpoint inhibitors for the treatment of breast cancer.
Academic Article	Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.
Academic Article	Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
Academic Article	BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.
Academic Article	Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial.
Academic Article	Differences Between Ipsilateral and Contralateral Early Parenchymal Enhancement Kinetics Predict Response of Breast Cancer to Neoadjuvant Therapy.
Academic Article	Clinical trials of immunotherapy in triple-negative breast cancer.
Academic Article	Highly accurate response prediction in high-risk early breast cancer patients using a biophysical simulation platform.
Academic Article	Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.
Academic Article	GLORIA: phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancer.
Academic Article	Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy.
Academic Article	The evolving therapeutic landscape of antibody-drug conjugates in breast cancer.
Academic Article	Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial.
Academic Article	Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
Academic Article	Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database.
Concept	Poly(ADP-ribose) Polymerase Inhibitors
Concept	Bevacizumab
Concept	Trastuzumab
Concept	Data Accuracy
Concept	Capecitabine
Concept	Pharmacogenomic Testing
Concept	Antineoplastic Agents, Immunological
Concept	Liquid Biopsy
Concept	ErbB Receptors
Academic Article	The Impact of Race and Age on Response to Neoadjuvant Therapy and Long-Term Outcomes in Black and White Women with Early-Stage Breast Cancer.
Academic Article	Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis.
Academic Article	Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.
Academic Article	Evaluation of multigene assays as predictors for response to neoadjuvant chemotherapy in early-stage breast cancer patients.
Academic Article	The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer.
Academic Article	Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer.
Academic Article	Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence.
Academic Article	A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer.
Academic Article	Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations.
Academic Article	Demographic and Clinical Characteristics Associated With Familiarity, Interest, and Use of Integrative Therapies Among Patients With Breast Cancer.
Academic Article	Stress, Isolation, and Sleep Quality among Breast Cancer Survivors throughout the COVID-19 Pandemic: A Longitudinal Study in a Multi-Ethnic Cohort.
Academic Article	Bilateral asymmetry of quantitative parenchymal kinetics at ultrafast DCE-MRI predict response to neoadjuvant chemotherapy in patients with HER2+ breast cancer.
Academic Article	Racial/Ethnic Disparities in Telemedicine Utilization and Satisfaction Among Breast Cancer Patients During the COVID-19 Pandemic: A Mixed-Methods Analysis.
Academic Article	Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.
Academic Article	Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
Academic Article	Validation of the RSClin risk calculator in the National Cancer Data Base.
Academic Article	Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
Academic Article	Racial differences in familiarity, interest, and use of integrative medicine among patients with breast cancer.
Academic Article	Androgen receptor agonism in advanced oestrogen receptor-positive breast cancer.
Academic Article	Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.
Academic Article	The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC).

Search Criteria

Receptor
ErbB
2